1. Home
  2. COGT vs CWH Comparison

COGT vs CWH Comparison

Compare COGT & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • CWH
  • Stock Information
  • Founded
  • COGT 2014
  • CWH 1966
  • Country
  • COGT United States
  • CWH United States
  • Employees
  • COGT N/A
  • CWH N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • CWH Retail-Auto Dealers and Gas Stations
  • Sector
  • COGT Health Care
  • CWH Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • CWH Nasdaq
  • Market Cap
  • COGT 1.1B
  • CWH 1.1B
  • IPO Year
  • COGT 2018
  • CWH 2016
  • Fundamental
  • Price
  • COGT $16.19
  • CWH $14.88
  • Analyst Decision
  • COGT Strong Buy
  • CWH Strong Buy
  • Analyst Count
  • COGT 11
  • CWH 9
  • Target Price
  • COGT $21.20
  • CWH $21.22
  • AVG Volume (30 Days)
  • COGT 1.9M
  • CWH 1.9M
  • Earning Date
  • COGT 11-11-2025
  • CWH 10-27-2025
  • Dividend Yield
  • COGT N/A
  • CWH 3.38%
  • EPS Growth
  • COGT N/A
  • CWH N/A
  • EPS
  • COGT N/A
  • CWH N/A
  • Revenue
  • COGT N/A
  • CWH $6,318,924,000.00
  • Revenue This Year
  • COGT N/A
  • CWH $4.92
  • Revenue Next Year
  • COGT N/A
  • CWH $7.08
  • P/E Ratio
  • COGT N/A
  • CWH N/A
  • Revenue Growth
  • COGT N/A
  • CWH 5.15
  • 52 Week Low
  • COGT $3.72
  • CWH $11.17
  • 52 Week High
  • COGT $16.46
  • CWH $25.97
  • Technical
  • Relative Strength Index (RSI)
  • COGT 74.84
  • CWH 35.58
  • Support Level
  • COGT $15.26
  • CWH $15.38
  • Resistance Level
  • COGT $16.22
  • CWH $16.78
  • Average True Range (ATR)
  • COGT 0.71
  • CWH 0.64
  • MACD
  • COGT 0.21
  • CWH -0.17
  • Stochastic Oscillator
  • COGT 92.27
  • CWH 3.47

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

Share on Social Networks: